Amaurosis in patients with giant cell arteritis: treatment with anti-tumour necrosis factor-alpha.
Torrente
S V
SV
Güerri
R C
RC
Pérez-García
C
C
Benito
P
P
Carbonell
J
J
D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001766:Blindness / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D013700:Giant Cell Arteritis / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D018917:Optic Neuropathy, Ischemic / Q000188:drug therapy / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab